Steatosis Colorimetric Assay Kit, Cayman Chemical

Supplier: Cayman Chemical Company

10012643-1
75817-252EA 271.9 USD
75817-252
Steatosis Colorimetric Assay Kit, Cayman Chemical
Assays Cellular Assays

A colorimetric screening assay for hepatoxicity assessment.


  • Detect excessive lipid accumulation in cells
  • Assess by microscopy or plate reader
  • An inducer of lipid accumulation is included as a positive control


Steatosis, also known as fatty liver, is a pathological process characterized by abnormal accumulation of lipid within cells. While simple steatosis may not be associated with significant impairment of liver function, excessive fat accumulation can lead to cirrhosis and even liver failure. The molecular mechanisms involved in non-alcoholic steatosis are poorly understood and little information is available on the pathway(s) responsible for progressive hepatocellular damage following lipid accumulation. Determining hepatotoxicity is an essential component of the drug discovery process and includes steatosis as one of the key parameters evaluated. Cayman’s Steatosis Colorimetric Assay Kit provides a convenient tool for evaluating steatosis risk of drug candidates. In this assay, Oil Red O is used to stain neutral lipids in hepatocytes. Lipid accumulation is then quantified using a plate reader after the dye is extracted from the lipid droplets. Chloroquine is included in the kit as a positive control.

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR